Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases The Short-Term and Long-Term Outcomes: Workshop Report (2011) / Chapter Skim
Currently Skimming:
Appendix F; Speaker Biosketches
Appendix F; Speaker Biosketches
Pages 531-542
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 531... ...
is the founder of the Lyme Disease Research Foundation of Maryland, a public nonprofit organization founded to promote research 531
|
From page 532... ...
Dr. Bockenstedt is a member of the Ad Hoc Lyme Disease Study Group and served on the panel that revised the clinical practice guidelines for the diagnosis and treatment of Lyme disease, human granulocytic anaplasmosis, and babesiosis, published in 2006 by the Infectious Diseases Society of America.
|
From page 533... ...
His basic interests have been in microbial toxins, but he has also been involved in a number of clinical trials. For the last 20 years, he has been interested in Lyme disease, and he continues to practice and do research on the topic.
|
From page 534... ...
His primary focus in Lyme disease over the last 10 years has been on identifying improved diagnostic tests and biomarkers of treatment response and on evaluating different treatments for patients with chronic symptoms that have persisted despite standard courses of antibiotic therapies for Lyme disease. Howard Ginsberg, Ph.D.
|
From page 535... ...
At the University of Texas Medical Branch, she established an independent research career in Ehrlichial and Rickettsial diseases with particular focus on protective immunity and immunopathogensis of this tick-borne emerging infectious disease. Her research on Rickettsial and Ehrlichial immunity, pathology, pathogenesis, and pathophysiology included important contributions to elucidating the protective or pathogenic immune mechanisms against Rickettsiae and Ehrlichiae that contribute to the development of mild or severe Ehrlichial and Rickettsial diseases.
|
From page 536... ...
In Lyme disease, his group studied the cost-effectiveness of the Lyme vaccine, studied long-term outcomes of Lyme disease, identified barriers to tick removal and avoidance, and conducted a clinical trial of over 30,000 travelers demonstrating the effectiveness of a novel health educational intervention in preventing Lyme and other tickborne illnesses. He is a graduate of Johns Hopkins University in philosophy and chemistry, Harvard Medical School, and the Harvard School of Public Health where he studied tropical public health and epidemiology.
|
From page 537... ...
is associate professor in the Departments of Pathology and Microbiology and Immunology at the University of Texas Medical Branch at Galveston. In addition to his academic appointments, he is a scientist in the Sealy Center for Vaccine Development, and a member of the Center for Biofense and Emerging Infectious Diseases and the Institute of Human Infections and Immunity.
|
From page 538... ...
. His current responsibilities include surveillance, research, and prevention activities for Lyme disease, plague, tularemia, and tick-borne relapsing fever.
|
From page 539... ...
The LBU provides laboratory diagnostic and clinical advisory service on Lyme disease and other tick-borne infections for the UK. She graduated in medicine from Dublin and trained in general medicine and family practice in the UK before specializing in microbiology and infectious diseases.
|
From page 540... ...
His current research focuses on development of aerosolized animal models for rickettsiae, development of ultrasensitive diagnostic methods for rickettsial infections, and pathogenesis of rickettsial infections as it relates to molecular mechanisms of increased microvascular permeability.
|
From page 541... ...
He is an associate director of the North Carolina Statewide Infection Control Program and serves as director of the Regulatory Core for the UNC Clinical Translational Research Award. He is board-certified in internal medicine, infectious disease, critical care medicine, and preventive medicine.
|
From page 542... ...
At Westchester Medical Center, Dr. Wormser is chief of the section of infectious diseases, director and founder of the Infectious Diseases Fellowship Program, and director and founder of the Lyme Disease Diagnostic Center.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.